Comparison of efficacy and safety of first-line palliative chemotherapy with EOX and mDCF regimens in patients with locally advanced inoperable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma: a randomized phase 3 trial

The aim of the study was to compare efficacy and safety of first-line palliative chemotherapy with (EOX) epirubicin/oxaliplatin/capecitabine and (mDCF) docetaxel/cisplatin/5FU/leucovorin regimens for untreated advanced HER2-negative gastric or gastroesophageal junction adenocarcinoma. Fifty-six pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochenduszko, Sebastian, Puskulluoglu, Miroslawa, Konopka, Kamil, Fijorek, Kamil, Urbanczyk, Katarzyna, Budzynski, Andrzej, Matlok, Maciej, Lazar, Agata, Sinczak-Kuta, Anna, Pedziwiatr, Michal, Krzemieniecki, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564435/
https://www.ncbi.nlm.nih.gov/pubmed/26354521
http://dx.doi.org/10.1007/s12032-015-0687-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4564435/
https://www.ncbi.nlm.nih.gov/pubmed/26354521
http://dx.doi.org/10.1007/s12032-015-0687-7

Ejemplares similares